Transcutaneous electrical nerve stimulation (TENS) is a non-invasive method of using electric current produced by a small, battery-powered device to stimulate the nerves for pain relief. It helps relieve pain by interrupting the pain signals sent to the brain and causes the body to produce endogenous opioids that also help suppress pain. TENS machines are commonly used for acute and chronic pain conditions such as musculoskeletal pain, neuropathic pain, and postoperative and labor pain. The global TENS market has been growing at a steady pace in recent years owing to factors such as rising geriatric population prone to orthopedic conditions and associated pain, increasing preference for non-drug therapies among patients, and growing adoption of wearable devices for pain management.
Market Dynamics:
The global transcutaneous electrical nerve stimulation market is driven by the rising geriatric population worldwide prone to chronic pain conditions, growing prevalence of neuropathic and musculoskeletal disorders, and increasing need for non-drug pain therapies. However, availability of alternative drug-based therapies and lack of clinical efficacy data are some of the factors expected to restrain the market growth. Emergence of digital TENS devices with Bluetooth connectivity for remote monitoring presents lucrative opportunities. Innovation of wearable TENS devices integrated with technologies like AI for customized treatment based on pain intensity also holds promise.
Key Features of the Study:
- This report provides an in-depth analysis of the global transcutaneous electrical nerve stimulation market and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global transcutaneous electrical nerve stimulation market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include DJO, LLC, NeuroMetrix, Inc., Uroplasty, Inc., Zynex Medical, and Bioness, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global transcutaneous electrical nerve stimulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transcutaneous electrical nerve stimulation market
Detailed Segmentation-
- By Product Type
- Portable TENS
- Table Top TENS
- By Application Type
- By End User
- Hospitals
- Physiotherapy Clinics
- Rehabilitation Centers
- Home care
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Omron Healthcare, Inc.
- Nevro Corp.
- DJO Global, Inc.
- Zynex Medical
- COMPex
- ITO Co., Ltd.
- Beurer GmbH
- BTL
- Chattanooga International
- EMS Physio Ltd.
- BioMedical Life Systems, Inc.
- Current Solutions, LLC
- Zewa, Inc.
- Walgreen Co.
- Pain Management Technologies, Inc.
- OPTP
- Roscoe Medical